Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
12:40pm, Thursday, 30'th Oct 2025
Metsera has become the obesity drug market's hottest ticket.
10 Ideal 'Safer' Dividend Buys From 38 Of 68 October Graham Value All-Stars (GVAS)
11:51am, Thursday, 30'th Oct 2025
The article analyzes the top large-cap value (GASV) stocks using YCharts' Value Score and Ben Graham Formula to identify fair-priced, high-yield dividend opportunities. Ten of eighteen 'safer' lowest-
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
11:39am, Thursday, 30'th Oct 2025
On Thursday, Metsera Inc. (NASDAQ:MTSR) received an unsolicited acquisition proposal from Novo Nordisk A/S (NYSE:NVO).
What Analyst Projections for Key Metrics Reveal About Pfizer (PFE) Q3 Earnings
10:16am, Thursday, 30'th Oct 2025
Evaluate the expected performance of Pfizer (PFE) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Novo Nordisk says offer for Metsera adheres to restrictions under Pfizer deal
09:52am, Thursday, 30'th Oct 2025
Novo Nordisk said on Thursday that it had adhered to all restrictions under the Pfizer merger agreement in its unsolicited offer for drugmaker Metsera , and that the value of its proposal far exceeded
Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker.
07:11am, Thursday, 30'th Oct 2025
Denmark's Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.
Metsera Receives Unsolicited Proposal from Novo Nordisk
07:07am, Thursday, 30'th Oct 2025
Metsera Declares Novo Nordisk Proposal "Superior" Novo Nordisk Proposal Values Metsera at up to $77.75 per Share, a Total of Approximately $9 Billion Pursuant to Pfizer Merger Agreement, Metsera and P
Pfizer Addresses Proposal for Metsera
06:57am, Thursday, 30'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE: NVO) to acquire Metsera, Inc. (NASDAQ: MTSR). It is an attempt by a co
Novo Nordisk Moves to Outbid Pfizer With Up to $9 Billion Offer for Obesity Drug Developer Metsera
06:23am, Thursday, 30'th Oct 2025
Novo Nordisk said the proposal is currently subject to review by Metsera's board of directors.
Novo Nordisk gatecrashes Pfizer's takeover of obesity rival Metsera
06:06am, Thursday, 30'th Oct 2025
Novo Nordisk (NYSE:NVO) has attempted to gatecrash Pfizer Inc (NYSE:PFE, ETR:PFE)deal to buy obesity drug developer Metsera Inc (NASDAQ:MTSR), with an unsolicited offer of $6.5 billion, rising to a
Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports
05:47am, Thursday, 30'th Oct 2025
Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on
Prediction: Putting $1,000 Into These Dividend Stocks Could Pay Off for Years
04:15am, Thursday, 30'th Oct 2025
Verizon has hiked its dividends for 19 consecutive years, and today boasts a yield of about 7%. Pfizer has been paying dividends for 87 straight years.
Pharmaceutical Stocks To Keep An Eye On – October 28th
02:09am, Thursday, 30'th Oct 2025
Avidity Biosciences, Eli Lilly and Company, Regeneron Pharmaceuticals, Pfizer, Incyte, AbbVie, and Novo Nordisk A/S are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock
2 High-Yield Stocks With Fresh Catalysts
07:00pm, Wednesday, 29'th Oct 2025
A tobacco giant shifting to smoke-free products just raised its dividend by 8.9% as next-generation nicotine wins an ever-increasing slice of revenue. A pharmaceutical company trades at 8 times forwar
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
06:46pm, Tuesday, 28'th Oct 2025
Pfizer (PFE) closed at $24.5 in the latest trading session, marking a -1.09% move from the prior day.
